Carcinoma: all 6,719 studies

Page 1 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• Labyrinthin Vaccination in Veterans With Lung AdenocarcinomaNot yet recruitingNCT07859592Phase 2
• Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerRecruitingNCT07855965Phase 2
• ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCCNot yet recruitingNCT07844551Phase 2
• Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP TrialNot yet recruitingNCT07840456Phase 2
• Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid TumorsNot yet recruitingNCT07815951Phase 1
• JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureNot yet recruitingNCT07798921Phase 1
• Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 2
• An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUCRecruitingNCT07720284Phase 3
• Recurrence Mechanisms of Colorectal Adenoma After Resection and a Multi-Omics Research ProtocolNot yet recruitingNCT07683312
• Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerRecruitingNCT07667400Phase 1/2
• Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational StudyRecruitingNCT07652489
• Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With LorlatinibRecruitingNCT07633626
• Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell CarcinomaNot yet recruitingNCT07618793Phase 2
• Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand TherapyNot yet recruitingNCT07587814Not applicable
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNot yet recruitingNCT07574541Phase 2
• Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung CancerNot yet recruitingNCT07538193Not applicable
• Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC TrialNot yet recruitingNCT07529262Phase 3
• Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical PracticeRecruitingNCT07501780
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCRecruitingNCT07489066Phase 2
• The Application of Sentire Surgical System Plus Patient Side Single Arm in Robotic Colorectal SurgeryNot yet recruitingNCT07453706Not applicable
• Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive CisplatinRecruitingNCT07441681Phase 3
• A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)RecruitingNCT07430202Phase 1
• Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")RecruitingNCT07411599Phase 1/2
• IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerRecruitingNCT07408635Phase 2
• Evaluation of an EpCAM-Targeted Radiotracer in Epithelial TumorsRecruitingNCT07400263Not applicable
• TheraSphere Japan Pre-Market StudyRecruitingNCT07377487Not applicable
• MRinRT: Swansea University and SWWCC Collaboration Study.Not yet recruitingNCT07365124
• Long Term Prediction of MASH-related HCC Risk by ProteomicsNot yet recruitingNCT07332611
• Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for RadiotherapyEnrolling by invitationNCT07311057Phase 3
• Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal CancerRecruitingNCT07281768Phase 2
• Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.Not yet recruitingNCT07265076
• Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin CancerRecruitingNCT07257094
• A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)RecruitingNCT07252323Not applicable
• A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT07246668Phase 2
• Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC PatientsNot yet recruitingNCT07231809Not applicable
• Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerRecruitingNCT07227415Phase 1/2
• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)RecruitingNCT07227402Phase 3
• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT07222566Phase 3
• Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch SyndromeRecruitingNCT07201012Not applicable
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerRecruitingNCT07195734Phase 2
• The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational StudyNot yet recruitingNCT07180459
• Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell CarcinomaRecruitingNCT07156227Phase 1
• Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.RecruitingNCT07148128Phase 1/2
• Y-90 Treatment Response Using Transarterial RadioembolizationRecruitingNCT07145801Phase 2
• Primary Radiotherapy In MEtastatic Lung CancerRecruitingNCT07135882Phase 3
• A Study of PHN-012 in Patients With Advanced Solid TumorsRecruitingNCT07127874Phase 1
• AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)RecruitingNCT07038343Phase 1/2
• RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 StudyRecruitingNCT07030569
• A Prospective Single-Arm Study（NCLDR）Not yet recruitingNCT07028918Early Phase 1
• International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Enrolling by invitationNCT07023601Not applicable
• PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular CarcinomaRecruitingNCT07018518Phase 1
• Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive ChemoradiotherapyEnrolling by invitationNCT07016737Phase 3
• A Irinotecan Liposome Trial of in Advanced Neuroendocrine CarcinomaNot yet recruitingNCT07014540Phase 4
• ctDNA Monitoring in Patients With HCC and mCRCRecruitingNCT07001085Not applicable
• Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal CarcinomaRecruitingNCT07000643Phase 3
• Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationRecruitingNCT06997068Phase 2
• Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current ManagementRecruitingNCT06995664Not applicable
• Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT06995105Phase 1/2
• Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular CarcinomaNot yet recruitingNCT06994572Phase 1
• Clinical Application of PET Imaging Targeting Nectin-4 in Malignant TumorsNot yet recruitingNCT06994078Not applicable
• A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)RecruitingNCT06991868
• TACE Plus Ivonescimab for Unresectable Non-Metastatic HCCNot yet recruitingNCT06990620Phase 1
• Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06988956Phase 2
• TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical TrialNot yet recruitingNCT06987123Phase 2
• A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCCNot yet recruitingNCT06984718Phase 2
• A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial CarcinomaRecruitingNCT06982794
• Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck CancerRecruitingNCT06980038Phase 2
• FGF19 Overexpression Combination Unified Study in HCC-19RecruitingNCT06978933Phase 2
• Safety and Efficacy of Pucotenlimab in pLECCRecruitingNCT06969534Phase 2
• Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular CarcinomaRecruitingNCT06961617Phase 1
• Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabRecruitingNCT06961526Not applicable
• PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular CarcinomaRecruitingNCT06960954
• Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid TumorsRecruitingNCT06959706Phase 1
• Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal CarcinomaNot yet recruitingNCT06957938Phase 3
• Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular CarcinomaRecruitingNCT06950827
• Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid CarcinomaRecruitingNCT06950814
• Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06947759
• A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
• NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerRecruitingNCT06941857Phase 2
• Relationship Between FGF19 Overexpression and Disease PrognosisNot yet recruitingNCT06938451
• Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)Not yet recruitingNCT06928415
• Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical TreatmentNot yet recruitingNCT06923176Phase 4
• The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical StudyNot yet recruitingNCT06915350
• Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck CancerRecruitingNCT06914999Early Phase 1
• TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal CarcinomaRecruitingNCT06912711Phase 2
• Performance Evaluation of a Urine-based Methylation Assay for Urothelial CarcinomaNot yet recruitingNCT06912672
• SIRT Versus cTACE for Unresectable HCC (CHANCE2506)RecruitingNCT06909708Not applicable
• Neoadjuvant QL1706 Therapy for ESCCRecruitingNCT06908382Phase 2
• Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06907602Phase 2/3
• Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker AnalysisRecruitingNCT06905145
• Probiotics in Advanced Urothelial CarcinomaRecruitingNCT06904573Phase 2
• Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCCRecruitingNCT06904196Phase 2
• Toripalimab Adjuvant Therapy in Subjects With Resected Esophageal Squamous Cell Carcinoma Who Achieved Pathological Complete Response (pCR)Not yet recruitingNCT06903871Phase 2
• The Epidemiology of Patients Treated With ATZ+BEV in Real Life SettingNot yet recruitingNCT06903663
• JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival OutcomesNot yet recruitingNCT06901934
• Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"Not yet recruitingNCT06901908
• PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal CarcinomaNot yet recruitingNCT06900218Phase 3
• TACE Combined Surgery for the Resectable Huge HCCRecruitingNCT06898398
• Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06896396Phase 1/2
• The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCCNot yet recruitingNCT06895369Phase 2

← Carcinoma overview